Coronary Artery Disease News and Research

Latest Coronary Artery Disease News and Research

FFR-guided intervention strategy can improve patient outcomes: Study

St. Jude Medical, Inc., a global medical device company, today announced that an analysis of the benefits to using a Fractional Flow Reserve-guided intervention strategy found that the technology can improve patient outcomes while saving millions of Euros.

30 Apr 2011

Legislative approaches needed to address obesity epidemic in Canada

With the increase in numbers of overweight children and young adults, Canada and other developed countries are facing an obesity epidemic and legislative approaches are required to address this issue, states an article in CMAJ (Canadian Medical Association Journal).

28 Apr 2011

Stereotaxis launches Stereotaxis Epoch solution for electrophysiology lab

Stereotaxis, Inc. today announces the introduction of its new Stereotaxis Epoch platform, a comprehensive solution for any electrophysiology lab which combines the recognized benefits of remote magnetic catheter control, the efficiency of remote robotic device manipulation, and the power of the Odyssey platform, enabling highly sophisticated procedural data integration and transmission.

27 Apr 2011

ACC/AHA release consensus document to help clinicians reduce risk of hypertension in older adults

Hypertension is very common among older adults. 64 percent of older men and 78 percent of older women have high blood pressure, placing them at heightened risk for heart disease including heart failure, stroke, coronary artery disease and atrial fibrillation, as well as chronic kidney disease and diabetes mellitus.

26 Apr 2011

Boston Scientific launches ION Paclitaxel-Eluting Platinum Chromium Coronary Stent System

Boston Scientific Corporation today announced U.S. Food and Drug Administration (FDA) approval and launch of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System, the Company's third-generation drug-eluting stent technology.

25 Apr 2011

New study: Children born with HIV are now faring well into adolescence, adulthood

Once facing an almost certain death sentence, most children born with HIV are now faring well into adolescence and adulthood, according to a newly published study co-authored by Tulane infectious diseases expert Dr. Russell Van Dyke. The study was published in the Journal of Acquired Immune Deficiency Syndromes.

22 Apr 2011

Two Canadian health researchers earn UBC recognition

Two of Canada's most eminent health researchers - Dr. Jacques Genest at McGill University and Dr. Michael Hayden at the University of British Columbia - have been awarded the inaugural Margolese National Brain and Heart Disorders Prizes, the most lucrative prizes bestowed by UBC.

22 Apr 2011

InfraReDx's LipiScan IVUS Coronary Imaging System receives European CE Mark approval

InfraReDx, Inc., a medical device company providing intelligent cardiovascular diagnostic imaging technologies, today announced it has received CE Mark approval to begin commercialization of the LipiScan™ IVUS Coronary Imaging System throughout Europe.

20 Apr 2011

Non-alcoholic fatty liver disease linked to coronary artery disease

Because of the prevalence of obesity in our country, many Americans are expected to develop a serious condition called non-alcoholic fatty liver disease (NAFLD), which can lead to cirrhosis, fibrosis, and in some cases liver failure. It is also one of the best predictors for coronary artery disease.

18 Apr 2011

Researchers discover strategy that promotes new blood vessel formation

Researchers at The University of Western Ontario have discovered a strategy for stimulating the formation of highly functional new blood vessels in tissues that are starved of oxygen. Dr. Geoffrey Pickering and Matthew Frontini at the Schulich School of Medicine & Dentistry developed a strategy in which a biological factor, called fibroblast growth factor 9, is delivered at the same time that the body is making its own effort at forming new blood vessels in vulnerable or damaged tissue.

18 Apr 2011

Boehringer Ingelheim's dabigatran etexilate receives positive opinion from EMA committee

Boehringer Ingelheim's novel oral anticoagulant dabigatran etexilate, received a positive opinion from the European Medicines Agency's medicinal committee today.

16 Apr 2011

Longitudinal displacement in carotid artery reflects both degree of atherosclerosis in artery and heart function

How your carotid artery moves can reveal your risk of a future heart attack, and it is now possible to study this vessel aspect in more detail thanks to a new technique which could eventually be used to identify patients with suspected coronary artery disease, reveals a thesis from the University of Gothenburg, Sweden.

12 Apr 2011

Two new studies on Veterans Affairs health care system

As recently as the 1990s, the Veterans Affairs health care system had a subpar reputation for quality, but two new studies of standard quality metrics, both led by Amal Trivedi, assistant professor of community health at Brown University and a physician at the Providence VA Medical Center, show that the system that cares for more than 5 million patients has improved markedly in the last decade.

8 Apr 2011

ICD therapy can improve ischemic cardiomyopathy survival rates

Most patients with ischemic cardiomyopathy and dilated cardiomyopathy who have an implantable cardioverter-defibrillator now live more than seven years and those ICD patients with hereditary heart disease can live for decades, based on a scientific paper that will be presented at the American College of Cardiology Scientific Sessions in New Orleans, April 1-3.

6 Apr 2011

New data finds 50% decline in heart surgery wait times in Alberta and BC

New data from the University of Calgary's Faculty of Medicine shows that wait times for a number of heart surgeries have gone down close to 50 per cent in Alberta and British Columbia.

6 Apr 2011

MR patients treated with Abbott MitraClip system demonstrate clinical benefits of initial treatment at two years

Abbott today announced data from its EVEREST II (Endovascular Valve Edge-to-Edge REpair STudy) study showing that patients with significant mitral regurgitation (MR) treated with the company's investigational percutaneous catheter-based MitraClip® system continue to demonstrate the clinical benefits of initial treatment shown at one year out to two years, including improvements in heart function and reductions in symptoms.

5 Apr 2011

Positive outcomes from Medtronic's Resolute drug-eluting stent against coronary artery disease

Results of two major clinical studies presented at ACC.11 - the 60th Annual Scientific Session & Expo of the American College of Cardiology - demonstrate that the Resolute drug-eluting stent from Medtronic, Inc., provides a positive and persistent treatment effect for a wide variety of patients with coronary artery disease.

5 Apr 2011

Coronary computed tomographic angiography to evaluate acute chest pain reduces hospital admissions

Hospital admissions at Stony Brook University Medical Center on Long Island were significantly reduced when using coronary computed tomographic angiography (CCTA) to evaluate patients presenting in the emergency department (ED) with acute chest pain (ACP), according to research results presented during a scientific session at the American College of Cardiology's 60th Annual Scientific Session and Expo in New Orleans on April 3.

4 Apr 2011

Abbott's XIENCE V Coronary Stent System data presented at ACC meeting

A pooled analysis of the SPIRIT II, III, IV and COMPARE trials presented today further reinforces the positive clinical performance of Abbott's market-leading XIENCE V Everolimus Eluting Coronary Stent System.

4 Apr 2011

BSX presents ION and TAXUS Stent trial data against coronary artery disease at ACC meeting

Boston Scientific Corporation today announced results from a pooled patient-level analysis of its PERSEUS and TAXUS ATLAS clinical trial data, demonstrating differences in safety and efficacy outcomes favoring the next-generation ION Platinum Chromium Paclitaxel-Eluting Stent System compared to the currently available TAXUS Liberte Paclitaxel-Eluting Stent System.

4 Apr 2011

Coronary Artery Disease News and Research

Latest Coronary Artery Disease News and Research

FFR-guided intervention strategy can improve patient outcomes: Study

Legislative approaches needed to address obesity epidemic in Canada

Stereotaxis launches Stereotaxis Epoch solution for electrophysiology lab

ACC/AHA release consensus document to help clinicians reduce risk of hypertension in older adults

Boston Scientific launches ION Paclitaxel-Eluting Platinum Chromium Coronary Stent System

New study: Children born with HIV are now faring well into adolescence, adulthood

Two Canadian health researchers earn UBC recognition

InfraReDx's LipiScan IVUS Coronary Imaging System receives European CE Mark approval

Non-alcoholic fatty liver disease linked to coronary artery disease

Researchers discover strategy that promotes new blood vessel formation

Boehringer Ingelheim's dabigatran etexilate receives positive opinion from EMA committee

Longitudinal displacement in carotid artery reflects both degree of atherosclerosis in artery and heart function

Two new studies on Veterans Affairs health care system

ICD therapy can improve ischemic cardiomyopathy survival rates

New data finds 50% decline in heart surgery wait times in Alberta and BC

MR patients treated with Abbott MitraClip system demonstrate clinical benefits of initial treatment at two years

Positive outcomes from Medtronic's Resolute drug-eluting stent against coronary artery disease

Coronary computed tomographic angiography to evaluate acute chest pain reduces hospital admissions

Abbott's XIENCE V Coronary Stent System data presented at ACC meeting

BSX presents ION and TAXUS Stent trial data against coronary artery disease at ACC meeting

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Coronary Artery Disease News and Research

Latest Coronary Artery Disease News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in